Diabetic Mouse Cardiac Microvascular Endothelial Cells

Diabetic Mouse Cardiac Microvascular Endothelial Cells

Cat.No.: CSC-C9300J

Species: Mouse

Source: Heart

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9300J
Description
Diabetic Mouse Cardiac Microvascular Endothelial Cells from Creative Bioarray are isolated from the heart of Diabetic (db/db) mice. Diabetic Mouse Cardiac Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based solution for 2 min and incubated in Creative Bioarray’s Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryopreserved in vials. Each vial contains at least 0.5×10^6cells per ml. The method we use to isolate primary endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic beads pre-coated with secondary antibody.
Species
Mouse
Source
Heart
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Diabetes
Storage
Liquid Nitrogen (-180 °C).
Quality Control
Diabetic Mouse Cardiac Microvascular Endothelial Cells are tested for expression of markers using antibody, VE-cadherin; AF1002 or CD31/PECAM-1 by immunofluorescence staining or FACS. Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-7 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Diabetic Mouse Cardiac Microvascular Endothelial Cells are primary endothelial cells isolated from the cardiac microvasculature of diabetic mice. They provide a disease-relevant model for investigating endothelial mechanisms underlying coronary microvascular dysfunction and diabetic cardiomyopathy. Their principal advantage is the combination of cardiac tissue origin and prior exposure to the diabetic environment in vivo, enabling investigation of disease-associated cellular alterations beyond responses to short-term glucose treatment alone.

These cells are particularly valuable for studying the relationship between metabolic stress and endothelial dysfunction. Research using cardiac microvascular endothelial cells isolated from db/db mice has demonstrated increased intracellular reactive oxygen species, reduced glycolytic reserve, and altered expression of genes involved in mitochondrial energy metabolism. Reduced proliferation and increased apoptosis were also observed, illustrating their utility for examining how diabetes affects endothelial survival and microvascular maintenance.

When compared with appropriately matched non-diabetic controls, these cells facilitate evaluation of disease-dependent responses and help connect cellular findings with cardiac vascular outcomes in vivo. Together, their tissue specificity and diabetic donor background make them a valuable resource for mechanistic and preclinical studies of diabetes-associated cardiac microvascular disease.

Adipsin Mitigates Cardiac Microvascular Injury in Diabetic Cardiomyopathy

This study was designed to investigate the potential role of Adipsin in the regulation of diabetic microvascular complications, as well as the underlying mechanism involved. Experimental diabetes was induced in mice with adipose tissue-specific Adipsin overexpression (AdipsinLSL/LSL-Cre) and their respective control (AdipsinLSL/LSL). In addition, cultured cardiac microvascular endothelial cells (CMECs) were subjected to high glucose/palmitic acid (HG + PA) treatment to simulate diabetes for a mechanistic approach. CMECs were treated with exosomes secreted by different mouse adipose tissues (AdipsinLSL/LSL and AdipsinLSL/LSL-Cre mice).

Adipsin-enriched exosomes were taken up by CMECs, inhibited CMECs apoptosis, and increased CMECs proliferation under HG + PA treatment. Adipsin-enriched exosomes also accelerated wound healing, rescued cell migration defects, and promoted tube formation in response to HG + PA challenge. Furthermore, Adipsin-enriched exosomes maintained adherens junctions at endothelial cell borders and reversed endothelial hyperpermeability disrupted by HG + PA insult. Together, these findings favor the vital role of Adipsin in the regulation of CMECs adherens junctions integrity, revealing its promises as a treatment target against diabetic coronary microvascular dysfunction.

Adipsin promotes CMECs migration and tube formation while inhibits hyperpermeability in CMECs under diabetic condition.
Fig. 1. Adipsin promotes CMECs migration and tube formation while inhibits hyperpermeability in CMECs treated with HG + PA (Zhang, Xuebin, et al., 2023).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products